#Europe’s medicines watchdog said on Tuesday the benefits of #AstraZeneca’s Covid-19 #vaccine continue to outweigh the risks after several countries halted its use due to concerns about blood clots. EMA Executive Director Emer Cooke said there was no indication that the blood clot incidents, which he called “very rare” had been caused by the vaccine, but that experts were assessing that possibility.
REPLAY: EU regulator ‘convinced’ AstraZeneca benefit outweighs risk
